Interdiscipinary Leukemia Project Launches "What's New in t-AML"
This page features significant recent studies in therapy-related Acute Myeloid Leukemia. Studies are organized into three main sections: t-AML diagnosis and incidence, genetic abnormalities in t-AML, and t-AML treatment and outcomes. Where possible, links to the primary publications are included. The page can be found at https://t-aml.uchicago.edu/resources-publications/whats-new-in-t-aml/
The Interdisciplinary Leukemia Project is a six-part systems biology-based interdisciplinary attack on therapy-based Acute Myeloid Leukemia, a secondary cancer that strikes 8 to 10% of cancer survivors. The five year program includes high-throughput genomic screening, work in blood stem cells, clinical trials and high-level informatics, all focused on the same disease and pursued at the same time in a coordinated manner. While the primary goal of this project is to find answers surrounding this terrible disease, the hope is that by applying a systems-based approach to cancer research, the project will be able to change the way that cancer science is pursued.
"Thanks to the hard work, commitment, and compassion of scientists, researchers, and organizations like the Cancer Research Foundation, there is renewed hope for discovering better treatments and eventually a cure for cancer.
I commend all of you for your outstanding contributions to the field of cancer research. For five decades, your commitment to the crusade against cancer has given hope and comfort to people across the nation."
Former President of the United States
May 05, 1997